Delivery Order SPE2DB22D1106-SPE2DB24FFLY0

Award Date 9/10/24
Potential Completion Date 9/11/24
Potential Value $2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of NUCYNTA 50 MG TABLET 100S. The contract has a ceiling value of $1,263.09 and is a firm-fixed price contract with an ultimate completion date of September 12, 2024. Amerisourcebergen has been awarded this delivery order under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999, which serves as...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of NUCYNTA 100 MG TABLET 100S, a prescription pharmaceutical product. The contract has a firm fixed price of $4,535.72 and an ultimate completion date of September 4, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this order as part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of NUCYNTA 100 MG TABLET 100S. The contract has a ceiling value of $2,862.27 and a completion date of June 24, 2025. It is a firm fixed-price contract, with no set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00 and...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of NUCYNTA 75 MG TABLET 100S. The contract is a firm-fixed price delivery order with a ceiling value of $1,351.56 and an ultimate completion date of May 1, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of NUCYNTA 50 MG TABLET 100S. The $1,248.84 firm fixed price contract has a completion date of June 27, 2025. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This delivery order...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,432.38, is for the delivery of NUCYNTA 75 MG TABLET 100S, a pharmaceutical product. The contract has a period of performance through May 29, 2025 and is not set aside for any particular business type. AmerisourceBergen Drug Corp holds a significant...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of NUCYNTA 75 MG TABLET 100S. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $2,324.18 and an ultimate completion date of June 6, 2025. The contract is not set aside for any specific business type. AmerisourceBergen Drug Corp is a for-profit organization that serves as a critical supplier of medical...
This federal contract award, valued at $1,432.38, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NUCYNTA 75 MG TABLET 100S, a pharmaceutical product, and has an ultimate completion date of February 5, 2025. The contract is a Delivery Order under a Firm Fixed Price pricing type, with no set-aside designation. AmerisourceBergen Drug Corp maintains a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of NUCYNTA 75 MG TABLET 100S. The contract has a ceiling value of $2,148.57 and a final completion date of May 30, 2025. It is a firm-fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of NUCYNTA 75 MG TABLET 100S, a prescription pain medication. The $1,351.56 delivery order contract has a completion date of September 6, 2024 and is awarded under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025. AmerisourceBergen, a major pharmaceutical distributor, provides a wide range of...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB24FFLY0
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of NUCYNTA 75 MG TABLET 100S. The delivery order, valued at $2,027.31, has a firm fixed price and an ultimate completion date of September 11, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through December 2025 for delivering a range of medical commodities to support military treatment programs and facilities worldwide. This contract award does not have a set-aside designation.

Generated 12/10/24, 2:18 PM